60 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
60 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
60 DaysReady to play
Ready to play
A recent study has revealed that the new blood test, "Stockholm 3," significantly outperforms the traditional test in early detection of aggressive prostate cancer. The results showed that the new test successfully detects 90% of aggressive cases, compared to 74% for the conventional test, which could change screening methods and reduce unnecessary procedures. The test is still under evaluation and has not yet received official approvals.
Notice: This Is an AI-Generated Summary
Comments (0)